ACM
TAK icon

Aquatic Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Aquatic Capital Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-153,759
Closed -$2.85M – 1714
2026
Q1 		$2.85M Sell
153,759
-6,382
-4% -$112K 0.08% 294
2025
Q4 		$2.5M Buy
160,141
+114,182
+248% +$1.63M 0.07% 328
2025
Q3 		$673K Buy
+45,959
New +$683K 0.01% 796
2025
Q1 		– Sell
-180,927
Closed -$2.4M – 1614
2024
Q4 		$2.4M Buy
180,927
+61,927
+52% +$851K 0.06% 333
2024
Q3 		$1.69M Buy
119,000
+53,800
+83% +$763K 0.04% 395
2024
Q2 		$844K Sell
65,200
-68,200
-51% -$903K 0.03% 426
2024
Q1 		$1.85M Sell
133,400
-2,600
-2% -$37.8K 0.06% 263
2023
Q4 		$1.94M Buy
136,000
+49,100
+57% +$697K 0.05% 338
2023
Q3 		$1.34M Buy
86,900
+43,900
+102% +$680K 0.06% 290
2023
Q2 		$676K Buy
+43,000
New +$705K 0.04% 387
2022
Q4 		– Sell
-34,400
Closed -$446K – 1807
2022
Q3 		$446K Sell
34,400
-18,100
-34% -$252K 0.04% 435
2022
Q2 		$737K Buy
+52,500
New +$749K 0.24% 117

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Aquatic Capital Management's TAK Position: Q2 2026 in Review

Aquatic Capital Management sold out of Takeda Pharmaceutical (TAK) in Q2 2026, closing a stake of 153,759 shares — an estimated $2.85M sold.

Aquatic Capital Management first reported a position in TAK in Q2 2022 and held it in 12 quarters. The position peaked at $2.85M in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Aquatic Capital Management reported no remaining Takeda Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 153,759 Takeda Pharmaceutical shares in Q2 2026, an estimated $2.85M.
  • Aquatic Capital Management first reported a position in Takeda Pharmaceutical in Q2 2022 and held it in 12 quarters.
  • Aquatic Capital Management's Takeda Pharmaceutical position peaked at $2.85M in Q1 2026.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.